Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
- 1 November 1997
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 42 (5), 679-688
- https://doi.org/10.1002/ana.410420503
Abstract
To determine whether cerebrospinal fluid (CSF) viral burden measurements can assist in the evaluation of human immunodeficiency virus (HIV)‐associated neurocognitive disorders, we quantified HIV type 1 (HIV‐1) RNA in CSF. Because previous findings suggested that disease stage, lymphocytic pleocytosis, and HIV‐1 RNA levels in plasma may influence CSF viral burden, these variables were examined as potential modifying factors. HIV‐1 RNA levels were quantified by using a reverse transcriptase–polymerase chain reaction assay. Performance on a comprehensive neuropsychological (NP) battery was noted in 97 prospectively enrolled, HIV‐infected subjects. Among subjects with acquired immunodeficiency syndrome (AIDS) (4 lymphocytes), NP impairment was associated with significantly higher CSF RNA levels (3.1 vs 1.8 log10 copies/ml; p = 0.02); most impaired subjects met criteria for HIV‐associated dementia or minor cognitive–motor disorder. In subjects without AIDS, CSF RNA and NP impairment were unrelated. Before AIDS, CSF RNA was strongly correlated to plasma RNA and to pleocytosis, but in AIDS, CSF and plasma RNA were independent. In conclusion, we found elevated CSF HIV‐1 RNA levels in NP impaired subjects with AIDS. Before AIDS, systemic viral replication, possibly through CD4+ mononuclear cell trafficking, may govern virus levels in CSF, whereas in AIDS, CD4 cell depletion may unmask a correlation between increased productive central nervous system HIV infection and clinical neurocognitive disorders.Keywords
This publication has 42 references indexed in Scilit:
- Region-Specific Changes, Gene Duplications, and Random Deletions in the nef Gene from HIV Type 1-Infected Brain Tissues and Blood of a Demented PatientAIDS Research and Human Retroviruses, 1997
- Host factors and the pathogenesis of HIV-induced diseaseNature, 1996
- Virologic Markers of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid of Infected ChildrenThe Journal of Infectious Diseases, 1996
- JCV-DNA and BKV-DNA in the CNS Tissue and CSF of AIDS Patients and Normal Subjects. Study of 41 Cases and Review of the LiteratureJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Comparison of human immunodeficiency virus biological phenotypes isolated from cerebrospinal fluid and peripheral bloodJournal of Medical Virology, 1995
- Specific Diagnosis of Progressive Multifocal Leukoencephalopathy by Polymerase Chain ReactionThe Journal of Infectious Diseases, 1994
- Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system diseaseAIDS, 1991
- Assessment of Aids-related cognitive changes: Recommendations of the NIMH workshop on neuropsychological assessment approachesJournal of Clinical and Experimental Neuropsychology, 1990
- Cerebrospinal Fluid Abnormalities in Patients Without AIDS Who Are Seropositive for the Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985